News

Filter

Current filters:

Merck & Co

76 to 85 of 97538 results

FDA removes hold on CytRx's aldoxorubicin Phase III trials

FDA removes hold on CytRx's aldoxorubicin Phase III trials

20-01-2015

The US Food and Drug Administration has removed the partial clinical hold on biopharma oncology company…

aldoxorubicinBiotechnologyCytRxOncologyRegulationResearchUSA

Tiziana licenses potential cancer therapy milciclib from Nerviano

Tiziana licenses potential cancer therapy milciclib from Nerviano

20-01-2015

Oncology and immunology specialist Tiziana Life Sciences has exclusively licensed milciclib from Nerviano…

LicensingmilciclibNerviano Medical SciencesOncologyPharmaceuticalResearchTiziana

Eisai launches epilepsy treatment Exalief in Russia

Eisai launches epilepsy treatment Exalief in Russia

20-01-2015

Japanese drug major Eisai has announced that epilepsy drug Exalief (eslicarbazepine acetate) will soon…

EisaiExaliefMarkets & MarketingNeurologicalPharmaceuticalRussia

FDA approves Fresenius Kabi’s neostigmine methylsulfate injection

FDA approves Fresenius Kabi’s neostigmine methylsulfate injection

20-01-2015

Fresenius Kabi, a unit of the Germany-headquartered Fresenius Group, has received approval from the US…

FreseniusFresenius Kabineostigmine methylsulfateNeurologicalPharmaceuticalRegulationUSA

PharmaEngine says positive Phase III results achieved with pancreatic cancer candidate MM-398

20-01-2015

Taiwan's PharmaEngine says that the additional analyses from the global Phase III NAPOLI-1 study of MM-398…

Merrimack PharmaceuticalsMM-398OncologyPharmaceuticalPharmaEngineResearch

Success of India-developed meningitis A vaccine MenAfriVac

Success of India-developed meningitis A vaccine MenAfriVac

20-01-2015

Meningitis A, that threatens the lives of 450 million people across 26 countries in Africa's ‘Meningitis…

HealthcareIndiaMenAfriVacPharmaceuticalSerum Institute of IndiaSub-Saharan AfricaVaccines

Gedeon Richter and Actavis announce positive results from Phase III trial of cariprazine in schizophrenia

Gedeon Richter and Actavis announce positive results from Phase III trial of cariprazine in schizophrenia

20-01-2015

Hungary’s largest pharma company Gedeon Richter and Ireland-headquartered generics major Actavis have…

ActaviscariprazineGedeon RichterNeurologicalPharmaceuticalResearch

Bayer's Xarelto gets label update in Europe

Bayer's Xarelto gets label update in Europe

20-01-2015

German drug major Bayer has updated the label for its Xarelto (rivaroxaban) in Europe.

BayerCardio-vascularGermanyPharmaceuticalRegulationXarelto

MSF calls on GSK and Pfizer to slash pneumo vaccine price to $5

MSF calls on GSK and Pfizer to slash pneumo vaccine price to $5

20-01-2015

Médecins Sans Frontières (MSF) has called on UK pharma major GlaxoSmithKline and US pharma giant Pfizer…

GlaxoSmithKlineMSFPfizerPharmaceuticalPricingRest of the WorldVaccinationVaccines

76 to 85 of 97538 results

Back to top